Global Retirement Partners, LLC Bio N Tech Se Transaction History

Global Retirement Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$90.91 - $112.75 $25,636 - $31,795	-282 Reduced 97.58%	7 $0
Q2 2023 Jul 20, 2023	BUY	$102.58 - $129.66 $29,235 - $36,953	285 Added 7125.0%	289 $31,000
Q3 2022 Nov 03, 2022	BUY	$127.65 - $183.11 $510 - $732	4 New	4 $1,000
Q4 2020 Jan 13, 2021	SELL	$72.71 - $129.54 $9,815 - $17,487	-135 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$57.81 - $104.17 $7,804 - $14,062	135 New	135 $9,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.6B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.